Methotrexate shows the same efficacy and safety in the real world in all subtypes of JIA as in the controlled trial by Foedvari I, Wierk A

Characteristics of juvenile onset systemic sclerosis patients in an adult single centre cohort. Does this patient population present a survival bias? by Foeldvari I, Nihtanova S, Wierk A, Denton CP